MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts8888
Avg. Estimate0.52-0.44-0.9-1.42
Low estimate0.44-0.52-1.21-2.28
High estimate0.74-0.21-0.45-1.06
Year ago EPS-0.7-0.49-2.31-0.9
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts7787
Avg. Estimate125.6M2.55M131.73M36.57M
Low estimate124.48MN/A124M600k
High estimate127M6M143.87M98.91M
Year ago sales1.22M7M7.13M131.73M
Sales growth (year/est)10,228.90%-63.60%1,748.10%-72.20%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.6-0.47-0.46-0.55
Actual EPS-0.7-0.49-0.54-0.57
Difference-0.1-0.02-0.08-0.02
Surprise %-16.70%-4.30%-17.40%-3.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate0.52-0.44-0.9-1.42
7 days ago0.52-0.44-0.9-1.42
30 days ago0.33-0.45-1.08-1.43
60 days ago0.17-0.41-1.15-1.54
90 days ago0.26-0.42-0.97-1.06
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days7565
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.174.30%N/AN/AN/A
Next qtr.10.20%N/AN/AN/A
Current year61.00%N/AN/AN/A
Next year-57.80%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A